Health committee  I think you are referring to Philippe.

Health committee  Yes.

Health committee  Well that's actually a common side effect of most anxiolytic or anti-anxiety medications—

Health committee  —so some increasing anxiety is reported by some cannabis users as part of the short-lived withdrawal syndrome. It's more short-lived than withdrawal syndromes associated with benzodiazepines or barbiturates, which are less widely used now.

Health committee  Yes, that's right.

Health committee  I'm certainly not saying that I would recommend it as an academic enhancer. As an educator, that's certainly not something that I'm interested in doing.

Health committee  Rather, I'm referring to the results of the study that showed that in people who used both cannabis and tobacco, compared to tobacco alone, we see worse outcomes among the tobacco users. It has to do with the increased stigmatization of tobacco use.

Health committee  Well, I think you make a good point. As a former junior high school teacher, that's certainly something I consider a lot. How do we minimize the risks for vulnerable young people? I think we can look at the model that we've used for tobacco, where we have really, through accurat

Health committee  We need broad-based research. The conditions you mentioned are certainly good starting points. In our research with Canadian medical cannabis users, we found that a large proportion are also using cannabisto treat anxiety both on its own and in relation to their illness, and to a

Health committee  I think the directions for health providers is quite a good document in general. It's certainly fairly comprehensive. I was actually quite impressed with that document, yes.

Health committee  Thanks for inviting me. It's an honour to be here. Given the relatively brief time I have, I'd like to highlight five points that I think are particularly salient to the estimation of the health risks and dangers of cannabis. My first point provides a broad context for the discu